Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joyce Ndunguru"'
Autor:
Manase Kilonzi, Hamu J. Mlyuka, Fatuma Felix Felician, Dorkasi L. Mwakawanga, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, Agnes Jonathan, Paschal Ruggajo, Irene Kida Minja, Emmanuel Balandya, Julie Makani, Nathanael Sirili
Publikováno v:
Hemato, Vol 2, Iss 4, Pp 713-726 (2021)
Factors contributing to low use of HU among SCD patients exist in high-income countries. The latter leaves a drift of literature on factors for low utilization of HU in developing countries. This study aimed to explore the factors influencing the use
Externí odkaz:
https://doaj.org/article/b8e13958094f45f48d061a3514ef50fe
Autor:
Hilda J. Tutuba, Agnes Jonathan, William Lloyd, Fredrick Luoga, Emanuela Marco, Joyce Ndunguru, Benson R. Kidenya, Julie Makani, Paschal Ruggajo, Irene K. Minja, Emmanuel Balandya
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Sickle cell disease (SCD) is the single most important genetic cause of childhood mortality globally. Newborn screening (NBS) is the recommended intervention aimed at early identification of babies with SCD and their linkage to care. To e
Externí odkaz:
https://doaj.org/article/8e4477fda54d4a45b3380ee484967a75
Autor:
Agnes Jonathan, Hilda Tutuba, William Lloyd, Joyce Ndunguru, Julie Makani, Paschal Ruggajo, Irene K. Minja, Emmanuel Balandya
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
Background: Sickle cell disease (SCD) is a global public health priority due to its high morbidity and mortality. In Tanzania, SCD accounts for 7% of under-five mortality. Cost-effective interventions such as early diagnosis and linkage to care have
Externí odkaz:
https://doaj.org/article/4f3918d456054e059b9b28301c4e6130
Autor:
Emmanuela E Ambrose, Benson R Kidenya, Mwesige Charles, Joyce Ndunguru, Agnes Jonathan, Julie Makani, Irene K Minja, Paschal Ruggajo, Emmanuel Balandya
Publikováno v:
Journal of Blood Medicine. 14:37-47
Emmanuela E Ambrose,1 Benson R Kidenya,2 Mwesige Charles,3 Joyce Ndunguru,4 Agnes Jonathan,4 Julie Makani,4 Irene K Minja,4,5 Paschal Ruggajo,4,6 Emmanuel Balandya4,7 1Department of Paediatrics and Child Health, Catholic University of Health and Alli
Autor:
Ritah F Mutagonda, George Bwire, Raphael Zozimus Sangeda, Manase Kilonzi, Hamu Mlyuka, Joyce Ndunguru, Agnes Jonathan, Julie Makani, Irene Kida Minja, Paschal Ruggajo, Emmanuel Balandya, Appolinary AR Kamuhabwa
Publikováno v:
Infection and Drug Resistance. 15:4407-4418
Ritah F Mutagonda,1,2 George Bwire,3 Raphael Zozimus Sangeda,2,3 Manase Kilonzi,1 Hamu Mlyuka,1 Joyce Ndunguru,2,4 Agnes Jonathan,2,4 Julie Makani,2,4 Irene Kida Minja,2,5 Paschal Ruggajo,2,6 Emmanuel Balandya,2,7 Appolinary AR Kamuhabwa1 1Department
Autor:
Daniel Kandonga, Raphael Zozimus Sangeda, Upendo Masamu, Eliah Kazumali, Agnes Jonathan, Michael Msangawale, Winfrida Kaihula, Julieth Rwegalulila, Jesca Ondego, Hilda J. Tutuba, Joyce Ndunguru, Emmanuela E. Ambrose, Benson R. Kidenya, Mbonea Yonazi, Irene Kyomugisha, Wilson Mupfururirwa, Mario Jonas, Victoria Nembaware, Gaston Kuzamunu Mazandu, Andre Pascal Kengne, Ambroise Wonkam, Julie Makani, Emmanuel Balandya
Publikováno v:
Frontiers in Hematology. 2
BackgroundSickle cell disease (SCD) is a severe hereditary form of anemia that contributes between 50% and 80% of under-five mortality in Africa. Eleven thousand babies are born with SCD annually in Tanzania, ranking 4th after Nigeria, the Democratic
Autor:
Hamu J. Mlyuka, Manase Kilonzi, Ritah F. Mutagonda, Lulu Chirande, Wigilya P. Mikomangwa, David T. Myemba, Godfrey Sambayi, Dorkasi L. Mwakawanga, Joyce Ndunguru, Agnes Jonathan, Julie Makani, Paschal Ruggajo, Irene K. Minja, Emmanuel Balandya, Appolinary A. R. Kamuhabwa
Publikováno v:
Healthcare; Volume 10; Issue 11; Pages: 2223
Despite three decades of proven safety and effectiveness of hydroxyurea in modifying sickle cell disease (SCD), its accessibility is limited in Sub-Saharan Africa, which shares 75% of the world's SCD burden. Therefore, it is time to explore the barri
Autor:
Emmanuel Balandya, Julie Makani, Masamu Upendo, Irene K. Minja, Josephine Mgaya, Siana Nkya, Azra Gangji, Joyce Ndunguru, Paschal Ruggajo, Agnes Jonathan
Publikováno v:
Tanzania Journal of Science. 47:1165-1173
Tanzania is one of the countries with a high burden of sickle cell disease (SCD). Haemolytic anaemia is a clinical feature of SCD, and has been linked to major complications leading to morbidity and mortality. Treatment with hydroxyurea (HU) has show
Autor:
Manase Kilonzi, Dorkasi L. Mwakawanga, Fatuma Felix Felician, Hamu J. Mlyuka, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, Agnes Jonathan, Paschal Ruggajo, Irene Kida Minja, Emmanuel Balandya, Julie Makani, Nathanael Sirili
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 11; Pages: 6871
Tanzania is among the top five countries with a high burden of sickle cell disease (SCD) in the world. Even though the effects of SCD on quality of life have been documented in other countries including Nigeria and the United States of America, few a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a12b92206ad3b668c59a6511b7f3440
https://lirias.kuleuven.be/handle/20.500.12942/713610
https://lirias.kuleuven.be/handle/20.500.12942/713610
Autor:
Dorkasi L. Mwakawanga, Nathanael Sirili, Godfrey Sambayi, Lulu Chirande, Paschal Ruggajo, David T. Myemba, Julie Makani, Manase Kilonzi, Fatuma F. Felician, Ritah Mutagonda, Agnes Jonathan, Emmanuel Balandya, Wigilya P. Mikomangwa, Joyce Ndunguru, Irene K. Minja, Hamu J. Mlyuka
Publikováno v:
Hemato; Volume 2; Issue 4; Pages: 713-726
Hemato, Vol 2, Iss 48, Pp 713-726 (2021)
Hemato, Vol 2, Iss 48, Pp 713-726 (2021)
Factors contributing to low use of HU among SCD patients exist in high-income countries. The latter leaves a drift of literature on factors for low utilization of HU in developing countries. This study aimed to explore the factors influencing the use